Walleye Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-94,083
| Closed | -$1.1M | – | 2159 |
|
2025
Q1 | $1.1M | Buy |
94,083
+19,247
| +26% | +$225K | 0.01% | 806 |
|
2024
Q4 | $1.71M | Buy |
74,836
+30,336
| +68% | +$693K | ﹤0.01% | 754 |
|
2024
Q3 | $1.87M | Sell |
44,500
-48,000
| -52% | -$2.01M | ﹤0.01% | 798 |
|
2024
Q2 | $3.37M | Sell |
92,500
-8,362
| -8% | -$304K | 0.01% | 587 |
|
2024
Q1 | $5.13M | Sell |
100,862
-87,639
| -46% | -$4.46M | 0.01% | 436 |
|
2023
Q4 | $3.65M | Buy |
+188,501
| New | +$3.65M | 0.01% | 447 |
|
2022
Q2 | – | Sell |
-708
| Closed | -$27K | – | 2544 |
|
2022
Q1 | $27K | Buy |
+708
| New | +$27K | ﹤0.01% | 1838 |
|